STIM
Neuronetics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$97.41M
P/E Ratio
—
EPS
$-0.59
Beta
0.87
52W High
$4.85
52W Low
$0.80
50-Day MA
$1.41
200-Day MA
$2.37
Dividend Yield
—
Profit Margin
-26.20%
Forward P/E
—
PEG Ratio
—
About Neuronetics Inc
Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | $149.16M |
| Gross Profit (TTM) | $72.71M |
| EBITDA | $-27.63M |
| Operating Margin | -11.10% |
| Return on Equity | -134.90% |
| Return on Assets | -13.70% |
| Revenue/Share (TTM) | $2.26 |
| Book Value | $0.32 |
| Price-to-Book | 4.32 |
| Price-to-Sales (TTM) | 0.65 |
| EV/Revenue | 1.064 |
| EV/EBITDA | -2.02 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 85.70% |
| Shares Outstanding | $69.58M |
| Float | $28.68M |
| % Insiders | 31.08% |
| % Institutions | 64.06% |
Historical Volatility
HV 10-Day
113.86%
HV 20-Day
117.53%
HV 30-Day
111.35%
HV 60-Day
114.72%
HV Rank
80.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.33 target)
2
Strong Buy1
BuyData last updated: 4/17/2026